Loeb Partners Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-650
| Closed | -$52K | – | 3 |
|
2019
Q1 | $52K | Sell |
650
-2,120
| -77% | -$170K | 1.07% | 24 |
|
2018
Q4 | $254K | Sell |
2,770
-4,800
| -63% | -$440K | 0.12% | 120 |
|
2018
Q3 | $716K | Sell |
7,570
-19,700
| -72% | -$1.86M | 0.26% | 77 |
|
2018
Q2 | $2.53M | Buy |
27,270
+14,790
| +119% | +$1.37M | 0.64% | 49 |
|
2018
Q1 | $1.18M | Sell |
12,480
-2,950
| -19% | -$279K | 0.51% | 52 |
|
2017
Q4 | $1.49M | Hold |
15,430
| – | – | 0.44% | 60 |
|
2017
Q3 | $1.37M | Sell |
15,430
-200
| -1% | -$17.8K | 0.42% | 59 |
|
2017
Q2 | $1.13M | Sell |
15,630
-250
| -2% | -$18.1K | 0.33% | 69 |
|
2017
Q1 | $1.04M | Buy |
15,880
+400
| +3% | +$26.1K | 0.31% | 77 |
|
2016
Q4 | $969K | Buy |
+15,480
| New | +$969K | 0.33% | 75 |
|
2016
Q3 | – | Sell |
-5,480
| Closed | -$339K | – | 153 |
|
2016
Q2 | $339K | Buy |
+5,480
| New | +$339K | 0.11% | 120 |
|
2015
Q3 | – | Sell |
-13,055
| Closed | -$877K | – | 165 |
|
2015
Q2 | $877K | Sell |
13,055
-7,000
| -35% | -$470K | 0.25% | 84 |
|
2015
Q1 | $1.17M | Sell |
20,055
-17,850
| -47% | -$1.04M | 0.34% | 78 |
|
2014
Q4 | $2.48M | Buy |
37,905
+18,900
| +99% | +$1.24M | 0.74% | 41 |
|
2014
Q3 | $1.1M | Hold |
19,005
| – | – | 0.36% | 75 |
|
2014
Q2 | $1.07M | Sell |
19,005
-69,150
| -78% | -$3.9M | 0.33% | 80 |
|
2014
Q1 | $4.53M | Hold |
88,155
| – | – | 1.52% | 17 |
|
2013
Q4 | $4.66M | Buy |
88,155
+42,500
| +93% | +$2.24M | 1.49% | 17 |
|
2013
Q3 | $2.04M | Hold |
45,655
| – | – | 0.69% | 40 |
|
2013
Q2 | $1.89M | Buy |
+45,655
| New | +$1.89M | 0.69% | 42 |
|